Literature DB >> 28863472

A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.

Anita K McElroy1,2, Rama S Akondy3, Jessica R Harmon2, Ali H Ellebedy3, Deborah Cannon2, John D Klena2, John Sidney4, Alessandro Sette4, Aneesh K Mehta5, Colleen S Kraft5,6, Marshall G Lyon5, Jay B Varkey5, Bruce S Ribner5, Stuart T Nichol2, Christina F Spiropoulou2.   

Abstract

A nurse who acquired Lassa virus infection in Togo in the spring of 2016 was repatriated to the United States for care at Emory University Hospital. Serial sampling from this patient permitted the characterization of several aspects of the innate and cellular immune responses to Lassa virus. Although most of the immune responses correlated with the kinetics of viremia resolution, the CD8 T-cell response was of surprisingly high magnitude and prolonged duration, implying prolonged presentation of viral antigens. Indeed, long after viremia resolution, there was persistent viral RNA detected in the semen of the patient, accompanied by epididymitis, suggesting the male reproductive tract as 1 site of antigen persistence. Consistent with the magnitude of acute T-cell responses, the patient ultimately developed long-term, polyfunctional memory T-cell responses to Lassa virus. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Lassa virus; T cells; biomarkers; human; immunology

Mesh:

Substances:

Year:  2017        PMID: 28863472      PMCID: PMC5853890          DOI: 10.1093/infdis/jix201

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

1.  Immunoglobulin M and G responses measured by immunofluorescence in patients with Lassa or Marburg virus infections.

Authors:  H Wulff; K M Johnson
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

2.  Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus.

Authors:  Delphine Pannetier; Stéphanie Reynard; Marion Russier; Alexandra Journeaux; Noël Tordo; Vincent Deubel; Sylvain Baize
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

3.  Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man.

Authors:  Juan C Zapata; Maria S Salvato
Journal:  Future Virol       Date:  2015-03-13       Impact factor: 1.831

4.  Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.

Authors:  John Sidney; Scott Southwood; Carrie Moore; Carla Oseroff; Clemencia Pinilla; Howard M Grey; Alessandro Sette
Journal:  Curr Protoc Immunol       Date:  2013-02

5.  Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses.

Authors:  Siddhartha Mahanty; Karen Hutchinson; Sudhanshu Agarwal; Michael McRae; Pierre E Rollin; Bali Pulendran
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

6.  A case-control study of the clinical diagnosis and course of Lassa fever.

Authors:  J B McCormick; I J King; P A Webb; K M Johnson; R O'Sullivan; E S Smith; S Trippel; T C Tong
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

7.  Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever.

Authors:  S Mahanty; D G Bausch; R L Thomas; A Goba; A Bah; C J Peters; P E Rollin
Journal:  J Infect Dis       Date:  2001-05-11       Impact factor: 5.226

8.  Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein.

Authors:  J ter Meulen; M Badusche; K Kuhnt; A Doetze; J Satoguina; T Marti; C Loeliger; K Koulemou; L Koivogui; H Schmitz; B Fleischer; A Hoerauf
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

9.  Functional interferon system is required for clearance of lassa virus.

Authors:  Nadezhda E Yun; Allison L Poussard; Alexey V Seregin; Aida G Walker; Jennifer K Smith; Judith F Aronson; Jeanon N Smith; Lynn Soong; Slobodan Paessler
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

10.  Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors - Final Report.

Authors:  Gibrilla F Deen; Nathalie Broutet; Wenbo Xu; Barbara Knust; Foday R Sesay; Suzanna L R McDonald; Elizabeth Ervin; Jaclyn E Marrinan; Philippe Gaillard; Ndema Habib; Hongtu Liu; William Liu; Anna E Thorson; Francis Yamba; Thomas A Massaquoi; Faustin James; Archchun Ariyarajah; Christine Ross; Kyle Bernstein; Antoine Coursier; John Klena; Marylin Carino; Alie H Wurie; Yong Zhang; Marion S Dumbuya; Neetu Abad; Baimba Idriss; Teodora Wi; Sarah D Bennett; Tina Davies; Faiqa K Ebrahim; Elissa Meites; Dhamari Naidoo; Samuel J Smith; Patricia Ongpin; Tasneem Malik; Anshu Banerjee; Bobbie R Erickson; Yongjian Liu; Yang Liu; Ke Xu; Aaron Brault; Kara N Durski; Jörn Winter; Tara Sealy; Stuart T Nichol; Margaret Lamunu; James Bangura; Sihem Landoulsi; Amara Jambai; Oliver Morgan; Guizhen Wu; Mifang Liang; Qiudong Su; Yu Lan; Yanzhe Hao; Pierre Formenty; Ute Ströher; Foday Sahr
Journal:  N Engl J Med       Date:  2015-10-14       Impact factor: 91.245

View more
  25 in total

1.  Persistence of Lassa Virus Associated With Severe Systemic Arteritis in Convalescing Guinea Pigs (Cavia porcellus).

Authors:  David X Liu; Donna L Perry; Lisa Evans DeWald; Yingyun Cai; Katie R Hagen; Timothy K Cooper; Louis M Huzella; Randy Hart; Amanda Bonilla; John G Bernbaum; Krisztina B Janosko; Ricky Adams; Reed F Johnson; Jens H Kuhn; Matthias J Schnell; Ian Crozier; Peter B Jahrling; Juan C de la Torre
Journal:  J Infect Dis       Date:  2019-05-05       Impact factor: 5.226

2.  Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.

Authors:  David W Hawman; Kimberly Meade-White; Elaine Haddock; Rumi Habib; Dana Scott; Tina Thomas; Rebecca Rosenke; Heinz Feldmann
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

3.  Lassa Virus, but Not Highly Pathogenic New World Arenaviruses, Restricts Immunostimulatory Double-Stranded RNA Accumulation during Infection.

Authors:  Elizabeth J Mateer; Junki Maruyama; Galen E Card; Slobodan Paessler; Cheng Huang
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

4.  CD4 T-cell depletion prevents Lassa fever associated hearing loss in the mouse model.

Authors:  Junki Maruyama; Rachel A Reyna; Megumi Kishimoto-Urata; Shinji Urata; John T Manning; Nantian Harsell; Rebecca Cook; Cheng Huang; Janko Nikolich-Zugich; Tomoko Makishima; Slobodan Paessler
Journal:  PLoS Pathog       Date:  2022-05-23       Impact factor: 7.464

5.  Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.

Authors:  Junki Maruyama; Elizabeth J Mateer; John T Manning; Rachel Sattler; Alexey V Seregin; Natalya Bukreyeva; Frank R Jones; Joseph P Balint; Elizabeth S Gabitzsch; Cheng Huang; Slobodan Paessler
Journal:  Vaccine       Date:  2019-09-24       Impact factor: 3.641

6.  siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease.

Authors:  Emily P Thi; Chad E Mire; Amy Ch Lee; Joan B Geisbert; Raul Ursic-Bedoya; Krystle N Agans; Marjorie Robbins; Daniel J Deer; Robert W Cross; Andrew S Kondratowicz; Karla A Fenton; Ian MacLachlan; Thomas W Geisbert
Journal:  J Clin Invest       Date:  2017-11-06       Impact factor: 14.808

7.  Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization.

Authors:  Kathryn M Hastie; Robert W Cross; Stephanie S Harkins; Michelle A Zandonatti; Anatoliy P Koval; Megan L Heinrich; Megan M Rowland; James E Robinson; Thomas W Geisbert; Robert F Garry; Luis M Branco; Erica Ollmann Saphire
Journal:  Cell       Date:  2019-08-08       Impact factor: 66.850

Review 8.  Lassa fever-induced sensorineural hearing loss: A neglected public health and social burden.

Authors:  Elizabeth J Mateer; Cheng Huang; Nathan Y Shehu; Slobodan Paessler
Journal:  PLoS Negl Trop Dis       Date:  2018-02-22

9.  Natural History of Aerosol Induced Lassa Fever in Non‑Human Primates.

Authors:  Isaac L Downs; Carl I Shaia; Xiankun Zeng; Joshua C Johnson; Lisa Hensley; David L Saunders; Franco Rossi; Kathleen A Cashman; Heather L Esham; Melissa K Gregory; William D Pratt; John C Trefry; Kyle A Everson; Charles B Larcom; Arthur C Okwesili; Anthony P Cardile; Anna Honko
Journal:  Viruses       Date:  2020-05-29       Impact factor: 5.048

10.  Identification of Common CD8+ T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone.

Authors:  Saori Sakabe; Jessica N Hartnett; Nhi Ngo; Augustine Goba; Mambu Momoh; John Demby Sandi; Lansana Kanneh; Beatrice Cubitt; Selma D Garcia; Brian C Ware; Dylan Kotliar; Refugio Robles-Sikisaka; Karthik Gangavarapu; Luis M Branco; Philomena Eromon; Ikponmwosa Odia; Ephraim Ogbaini-Emovon; Onikepe Folarin; Sylvanus Okogbenin; Peter O Okokhere; Christian Happi; Pardis C Sabeti; Kristian G Andersen; Robert F Garry; Juan Carlos de la Torre; Donald S Grant; John S Schieffelin; Michael B A Oldstone; Brian M Sullivan
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.